53
https://pubmed.ncbi.nlm.nih.gov/38117300
The serum of COVID-19 patients induces endothelial cell dysfunction through protease-activated receptor 2, suggesting a potential therapeutic target for mitigating endothelial dysfunction in COVID-19.